olopatadine (Patanol)

09/01/1998 - "The results indicate that olopatadine ophthalmic solution is safe and effective in the treatment of allergic conjunctivitis, with the 0.1% concentration of olopatadine being optimal. "
04/01/2003 - "As evidenced by significantly greater comfort and longer duration of lens wear, olopatadine provides superior comfort to contact lens wearers suffering from the signs and symptoms of seasonal allergic conjunctivitis, as induced by the CAC model."
10/01/2005 - "Olopatadine hydrochloride 0.1% is an effective agent for relieving the signs and symptoms of vernal keratoconjunctivitis. "
09/10/2006 - "The anti-allergic eye drop olopatadine is a safe and effective treatment for seasonal allergic conjunctivitis even in childhood. "
01/01/2015 - "To compare the safety and efficacy of olopatadine 0.77% with vehicle or olopatadine 0.2% in patients with allergic conjunctivitis in a conjunctival allergen-challenge clinical study. "

07/01/2009 - "When evaluating itching, olopatadine had a significant improvement at 30 minutes and after one week (p < 0.05). "
01/01/2015 - "Olopatadine 0.77% is superior to both its vehicle and olopatadine 0.2% for the treatment of allergen-mediated ocular itching and conjunctival redness. "
04/01/2008 - "Olopatadine 0.2% was found to be a safe and effective medication for the reduction of itching with a duration of action of up to 24 h. "
12/01/2007 - "Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge."
12/01/2011 - "In the studies reviewed, alcaftadine was more effective than placebo and at least as effective as olopatadine 0.01% in preventing ocular itching at 15 minutes and at 16 hours after administration. "

12/01/1995 - "These results indicate that KW-4679 may be useful for the treatment of allergic rhinitis."
11/01/2009 - "Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis."
01/01/2009 - "Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats."
06/01/2010 - "Olopatadine nasal spray is one of the newest treatments approved by the FDA for the management of allergic rhinitis. "
03/01/2010 - "Olopatadine nasal spray for the treatment of allergic rhinitis."

01/01/2012 - "Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria."
01/01/2009 - "Olopatadine in chronic idiopathic urticaria."
04/01/2002 - "Olopatadine was shown to be useful for the treatment of allergic rhinitis and chronic urticaria in double-blind clinical trials. "
07/01/2001 - "Olopatadine was shown to be useful for the treatment of allergic rhinitis and chronic urticaria in double-blind clinical trials. "
01/01/2015 - "Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study."

01/01/2009 - "Second-generation oral H1-antihistamines have become a mainstay of treatment for the symptoms of seasonal allergic rhinitis; however, the effect of olopatadine has not been widely reported to date. "
07/01/2010 - "Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study."
05/01/2006 - "Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo."
12/01/2005 - "Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis."
11/01/2005 - "Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar."